Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology

Aamir Javaid, Fawzi Zghyer, Chang Hwan Kim, Erin M. Spaulding, Nino Isakadze, Jie Ding, Daniel Kargillis, Yumin Gao, Faisal Rahman, Donald E. Brown, Suchi Saria, Seth S. Martin, Christopher M. Kramer, Roger S. Blumenthal, Françoise A. MarvelAmerican 2022 · DOI

Abstract

Machine learning (ML) refers to computational algorithms that iteratively improve their ability to recognize patterns in data. The digitization of our healthcare infrastructure is generating an abundance of data from electronic health records, imaging, wearables, and sensors that can be analyzed by ML algorithms to generate personalized risk assessments and promote guideline-directed medical management. ML's strength in generating insights from complex medical data to guide clinical decisions must be balanced with the potential to adversely affect patient privacy, safety, health equity, and clinical interpretability. This review provides a primer on key advances in ML for cardiovascular disease prevention and how they may impact clinical practice.
BibTeX
@inproceedings{javaid2022medicine,
  author = {Aamir Javaid and Fawzi Zghyer and Chang Hwan Kim and Erin M. Spaulding and Nino Isakadze and Jie Ding and Daniel Kargillis and Yumin Gao and Faisal Rahman and Donald E. Brown and Suchi Saria and Seth S. Martin and Christopher M. Kramer and Roger S. Blumenthal and Françoise A. Marvel},
  title = {{Medicine 2032: The future of cardiovascular disease prevention with machine learning and digital health technology}},
  booktitle = {American},
  year = {2022},
  doi = {10.1016/j.ajpc.2022.100379},
}

Loading related content...

Figure